Clinical trial
Safety Study for the Use of Rapamycin in Children With Familial Adenomatous…
NCT06308445 · University Hospital, Toulouse, Other · Not yet recruiting
Key facts
| NCT number | NCT06308445 |
|---|---|
| Title | Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis |
| Official title | Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis. |
| Acronym | RAPA-4-PAF |
| Lead sponsor | University Hospital, Toulouse, Other |
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Familial Adenomatous Polyposis |
| Intervention type | Drug |
| Interventions | Rapamycin |
| Enrollment | 25 |
| Start date | Aug 1, 2025 |
| Primary completion | Aug 1, 2030 |
| Completion | Aug 1, 2030 |
| First posted | Mar 13, 2024 |
| Last update posted | Jan 31, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: